anmelden
SMI Expanded
1.936,75
PKT
-10,22
PKT
-0,52
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.06.22 | UBS Buy | Jefferies & Company Inc. | |
| 08.06.22 | UBS Hold | Jefferies & Company Inc. | |
| 08.06.22 | UBS Underweight | Barclays Capital | |
| 08.06.22 | UBS Neutral | UBS AG | |
| 08.06.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 08.06.22 | UBS Sector Perform | RBC Capital Markets | |
| 08.06.22 | DocMorris Sell | UBS AG | |
| 07.06.22 | Richemont Buy | UBS AG | |
| 07.06.22 | Roche Hold | Deutsche Bank AG | |
| 07.06.22 | Zurich Insurance Overweight | Barclays Capital | |
| 07.06.22 | DocMorris Overweight | Barclays Capital | |
| 07.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 06.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | DocMorris Buy | Deutsche Bank AG | |
| 01.06.22 | Nestlé Buy | HSBC | |
| 01.06.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 01.06.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 01.06.22 | DocMorris Overweight | Barclays Capital | |
| 31.05.22 | UBS Hold | Jefferies & Company Inc. | |
| 31.05.22 | Givaudan Neutral | UBS AG | |
| 31.05.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 30.05.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 30.05.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 27.05.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 27.05.22 | Richemont Outperform | RBC Capital Markets | |
| 26.05.22 | Roche Hold | Deutsche Bank AG | |
| 26.05.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 26.05.22 | Roche Outperform | Bernstein Research | |
| 25.05.22 | Richemont Buy | UBS AG | |
| 25.05.22 | Richemont Overweight | Barclays Capital | |
| 25.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 24.05.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 24.05.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 24.05.22 | Richemont Buy | Jefferies & Company Inc. | |
| 23.05.22 | ams-OSRAM Neutral | UBS AG |